Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study
Lemoine, Maud, PhD, Shimakawa, Yusuke, PhD, Njie, Ramou, PhD, Taal, Makie, MSc, Ndow, Gibril, MD, Chemin, Isabelle, PhD, Ghosh, Sumantra, PhD, Njai, Harr F, PhD, Jeng, Adam, BSc, Sow, Amina, PhD, Toure-Kane, Coumba, Prof, Mboup, Souleymane, Prof, Suso, Penda, BSc, Tamba, Saydiba, Jatta, Abdullah, Sarr, Louise, MD, Kambi, Aboubacar, MD, Stanger, William, Bsc, Nayagam, Shevanthi, MD, Howell, Jessica, PhD, Mpabanzi, Liliane, PhD, Nyan, Ousman, Prof, Corrah, Tumani, Prof, Whittle, Hilton, Prof, Taylor-Robinson, Simon D, Prof, D'Alessandro, Umberto, Prof, Mendy, Maimuna, PhD, Thursz, Mark R, Prof
Published in The Lancet global health (01.08.2016)
Published in The Lancet global health (01.08.2016)
Get full text
Journal Article
Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis
Nguyen, Liem B Luong, Lemoine, Maud, Ndow, Gibril, Ward, Zachary J, Hallet, Timothy B, D'Alessandro, Umberto, Thursz, Mark, Nayagam, Shevanthi, Shimakawa, Yusuke
Published in The Lancet global health (01.01.2024)
Published in The Lancet global health (01.01.2024)
Get full text
Journal Article